BSE filing, NSE: LTM. Summary written from the filing by ALFA Finder's alert engine.
LTM Ltd: key numbers
- Share price
- ₹4,267.20
- Market cap
- ₹1,26,583 Cr
- Revenue (annual)
- ₹42,308 Cr
- Net profit (annual)
- ₹5,018 Cr
- P/E (TTM)
- 24.2×Sector 23.3×
- Promoter holding
- 69.01%+0.52% QoQ
- FII holding
- 6.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from LTM Ltd
All →LTM Bags ₹950 Cr Order from Large global banking and financial services firm
LTM secured a two-year strategic engagement with a global BFSI firm worth up to USD 100 million (₹950 Cr). Scope covers technology consolidation across banking functions.
- Value
- ₹950.0 Cr
- From
- Large global banking and financial services firm (unnamed)
- Execution
- 2 years with option to extend for 1 additional year
LTM Capacity Expansion
LTM launched its BlueVerse Industrial AI Lab in Chennai on October 23, 2026. The co-innovation hub enables enterprises to scale AI across physical operations and intelligent products.
LTM Investor Presentation: Key Takeaways
LTM reported Q2 FY27 revenue of USD 1.24 billion, up 5.1% YoY in CC. The firm is pivoting to an AI-centric model with AI revenue reaching 13.4% of total sales.
LTM Other Announcement
This filing presents the quarterly shareholding pattern of LTM Ltd as required under SEBI regulations. It contains no material corporate events or transactions.
LTM Product Launch
LTM launches BlueVerse ValueMesh, an AI execution fabric to industrialize AI across Oracle transformations. The product unifies AI-native delivery, intelligent automation, and managed services for enterprise clients.
LTM Management Change
LTM Limited has appointed Anupam Kumar as a Non-Executive Non-Independent Director, effective October 16, 2026.
Other product launch announcements
All →TVS Motor Company Product Launch
TVS Motor launched the TVS Ronin and TVS NTORQ XP in Mauritius alongside a new distribution partnership with Le Warehouse and 361. No financial value was disclosed.
Bharat Forge Product Launch
Bharat Forge's defence subsidiary KSSL unveiled the 120mm Rapid Attack Mortar System for Indian Armed Forces and international customers. No order value or contract was announced.
Lupin Product Launch
Lupin announced the European launch of its biosimilar Ranibizumab (Ranluspec) via commercial partner Sandoz. The launch covers Europe excluding Germany following European Commission approval.
Jeena Sikho Lifecare Product Launch
Jeena Sikho Lifecare launched ten new Ayurvedic healthcare products in the domestic market on November 11, 2026. The filing gives product-wise details under SEBI product-launch disclosure rules.
HCL Technologies Product Launch
HCLTech launched a pre-configured semiconductor PLM solution built on PTC Windchill, developed in collaboration with PTC. The release states no contract value or deal size, and the launch is a new product offering.
Morepen Laboratories Product Launch
Morepen launched Desloratadine Tablets USP 5 mg, its first US prescription generic, through subsidiary Morepen Bio Inc. It also filed a Sitagliptin ANDA with the US FDA.